Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Cancer Discovery
|
July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)
Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Journal of the American Medical Informatics Association : JAMIA
|
August 21, 2023
Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine
Timothy Bergquist, Thomas Schaffter, Yao Yan, et al.
Oncoimmunology
|
December 29, 2025
A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in <i>in vivo</i> and <i>ex vivo</i> models
Phurin Areesawangkit, Karen Pei-Yi Fong, Emma Niemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2016
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
Lori S Hart, JulieAnn Rader, Pichai Raman, et al.
Journal of Medicinal Chemistry
|
April 17, 2026
Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual Inhibitor
Bo Wei, Xiaolei Li, Jacob J Lacharity, et al.
Cancer Cell
|
July 9, 2014
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors
Sadhna R Vora, Dejan Juric, Nayoon Kim, et al.
Journal of Medicinal Chemistry
|
November 3, 2010
4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6
Young Shin Cho, Maria Borland, Christopher Brain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma
Julieann Rader, Mike R Russell, Lori S Hart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2016
Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma
Andrew C Wood, Kateryna Krytska, Hannah T Ryles, et al.
Journal of Medicinal Chemistry
|
March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer
Heather E Burks, Tinya Abrams, Christina A Kirby, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Cancer Discovery
|
July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)
Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Journal of the American Medical Informatics Association : JAMIA
|
August 21, 2023
Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine
Timothy Bergquist, Thomas Schaffter, Yao Yan, et al.
Oncoimmunology
|
December 29, 2025
A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in <i>in vivo</i> and <i>ex vivo</i> models
Phurin Areesawangkit, Karen Pei-Yi Fong, Emma Niemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2016
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
Lori S Hart, JulieAnn Rader, Pichai Raman, et al.
Journal of Medicinal Chemistry
|
April 17, 2026
Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual Inhibitor
Bo Wei, Xiaolei Li, Jacob J Lacharity, et al.
Cancer Cell
|
July 9, 2014
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors
Sadhna R Vora, Dejan Juric, Nayoon Kim, et al.
Journal of Medicinal Chemistry
|
November 3, 2010
4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6
Young Shin Cho, Maria Borland, Christopher Brain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma
Julieann Rader, Mike R Russell, Lori S Hart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2016
Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma
Andrew C Wood, Kateryna Krytska, Hannah T Ryles, et al.
Journal of Medicinal Chemistry
|
March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer
Heather E Burks, Tinya Abrams, Christina A Kirby, et al.
Page
of 7